8K8-11704-92743
2 vaccinations
4 coded responses
17 check-ins
4 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 26-30
- ZIP prefix
- 359 / AL
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-04
Registered in v-safe
-
2021-01-04
Dose 1 — Pfizer-BioNTech
- 2021-01-04
-
2021-01-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-06
-
2021-01-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-01-08
- 2021-01-09
- 2021-01-18
-
2021-01-22
Dose 2 — Pfizer-BioNTech
- 2021-01-22
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-31
-
2021-02-05
Survey response — day 14, dose 2MedDRA: Headache, Myalgia, Periorbital haemorrhage, Pyrexia, Rash — Feeling: Poor · Be unable to workFree text: Severe headache and muscle aches.. petechiae around my eyes and faces. Fever.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Survey response — day 21, dose 2MedDRA: Abdominal pain, Jaundice, Petechiae — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Petechiae, sub conjunctival hemorrhage, jaundice, severe arthralgia and myalgia, severe right upper quadrant abdominal pain with radiation through to my back and flank.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Report sent to call center — day 21, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-25
Survey response — 6 months, dose 2MedDRA: Hepatic enzyme increased, Hospitalisation, Jaundice hepatocellular, Pancreatitis acute — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Was hospitalized 2 weeks following my second vaccine injection with hepato-billiary jaundice, acute pancreatitis, and elevated liver enzymes. Spent a total of 10 days in the hospital.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-25
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-31
-
2022-01-22
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Covid19MedDRA releases: 2024-11 · check-in free text available
-
2022-01-22
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-24
- 2022-01-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Pfizer-BioNTech | |
| 2 | 2021-01-22 | Pfizer-BioNTech |
Call center
3 call center cases
3 unsuccessful
Free text
Release 3 — day 14, dose 2
Symptoms: Severe headache and muscle aches.. petechiae around my eyes and faces. Fever.
Release 4 — day 21, dose 2
Symptoms: Petechiae, sub conjunctival hemorrhage, jaundice, severe arthralgia and myalgia, severe right upper quadrant abdominal pain with radiation through to my back and flank.
Release 9 — 6 months, dose 2
Symptoms: Was hospitalized 2 weeks following my second vaccine injection with hepato-billiary jaundice, acute pancreatitis, and elevated liver enzymes. Spent a total of 10 days in the hospital.
Release 11 — 12 months, dose 2
Symptoms: Covid19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hepatic enzyme increased | ✓ | · | ✓ |
| SD | Hospitalisation | ✓ | · | ✓ |
| SD | Jaundice | ✓ | ✓ | ✓ |
| SD | Jaundice hepatocellular | ✓ | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Pancreatitis acute | ✓ | · | ✓ |
| SD | Periorbital haemorrhage | ✓ | ✓ | ✓ |
| SD | Petechiae | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release